NpFlamma® HGC 749
BCT-PNC1301-Q01010 dosesCHF 740.00
BCT-PNC1301-Q05050 dosesCHF 2'591.00
BCT-PNC1301-Q250250 dosesCHF 8'513.00
|Purity Chemicals||>95% (TLC)|
|Solubility||Soluble in DMSO or water.|
|Declaration||Manufactured by BioActs.|
|Other Product Data||
Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
|Shipping and Handling|
|Short Term Storage||+4°C|
|Long Term Storage||+4°C|
Keep cool and dry.
Protect from light.
|Use/Stability||Stable for at least 2 years after receipt when stored at +4°C.|
|Product Specification Sheet|
NpFlamma® HGC 749 is a near-infrared fluorescent contrast agent that can be used for in vivo and can be utilized in angiography and tumor imaging of passive targeting by tail vein injection. NpFlamma® HGC 749 is a colloid-size nanoparticle based on the combination of chitosan and Flamma® NIR 749 which is a near-infrared fluorescent dye, and hydrophobic interior of NpFlamma® can embed hydrophobic drugs. In conjunction with the effect of passive targeting, it can be utilized in efficient transport of drugs for tumor. Furthermore, carboxyl group on surface of NpFlamma® HGC 749 is developed to label proteome such as peptide and antibody or organic molecule such as amine. Due to advanced fluorescence technology of Flamma® NIR 749, NpFlamma® that results more effective research imaging has almost no toxicity and pharmacological adverse drug reactions. Application Type: In vivo. Fluorescent agent type: Vascular, Passive targeted. Particle size: 250 nm. Excitation ? Emission (nm): 750 / 782 nm.